Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CVS Corporation to Acquire 1,260 Eckerd Stores and PBM/MAIL Order Pharmacy Business in $2.15 Billion Transaction.


Business Editors

WOONSOCKET, R.I.--(BUSINESS WIRE)--April 5, 2004

CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file.  Corporation (NYSE NYSE

See: New York Stock Exchange
: CVS):

-- Will Create America's Leading Pharmacy Retailer With More Than

5,000 Stores in 36 States, and a $2 Billion PBM/Mail Order

Pharmacy Business Serving Approximately 30 Million Lives, with

Combined 2003 Revenues of $33 Billion

-- Transaction Expected To Be Accretive to Earnings and Cash Flow

in 2005 and Beyond

CVS Corporation (NYSE: CVS) today announced that it has entered into a definitive agreement under which it will acquire from J.C. Penney Company, Inc., approximately 1,260 Eckerd drug stores, located mainly in the southern United States The Southern United States—commonly referred to as the American South, Dixie, or simply the South—constitutes a large distinctive region in the southeastern and south-central United States. ; Eckerd Health Services health services Managed care The benefits covered under a health contract , which includes Eckerd's $1 billion mail order and pharmacy benefits management businesses; and three Eckerd distribution centers. The cash transaction is valued at $2.15 billion.

Following completion of the transaction, CVS will be America's leading pharmacy retailer with more than 5,000 locations in 36 states and the District of Columbia District of Columbia, federal district (2000 pop. 572,059, a 5.7% decrease in population since the 1990 census), 69 sq mi (179 sq km), on the east bank of the Potomac River, coextensive with the city of Washington, D.C. (the capital of the United States). . CVS' PharmaCare subsidiary will nearly double in size to more than $2 billion in annual revenues and will serve approximately 30 million lives. In total, CVS will fill approximately 13% of the nation's retail prescriptions. The combined 2003 revenues of CVS Corporation and the operations it has agreed to acquire were approximately $33 billion.

The majority of the stores CVS will acquire are located in Florida and Texas, while others are located in Louisiana, Oklahoma, Mississippi, Arizona, Missouri, Kansas and Alabama. The distribution centers being acquired are located near Dallas and Houston, Texas “Houston” redirects here. For other uses, see Houston (disambiguation).
Houston (pronounced /'hjuːstən/) is the largest city in the state of Texas and the
 and Orlando, Florida.

Tom Ryan, Chairman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of CVS Corporation, said: "This acquisition is a unique opportunity and is consistent with our long-term strategy of expanding our store base in the high-growth sun-belt markets. The demographics in these states are very favorable, as they are experiencing rapid population growth, particularly among seniors, resulting in pharmaceutical utilization rates among the highest in the nation.

"The addition of Eckerd Health Services to our PharmaCare subsidiary creates a national mail order, pharmacy benefits management and specialty pharmacy company with annual revenues in excess of $2 billion and approximately 30 million lives served. We believe we can drive further growth through the combination of its outstanding operations with those of PharmaCare. Moreover, with increased scale, PharmaCare will be in a better position to serve large corporate customers.

"CVS' track record of significantly improving the performance of acquired operations will serve us well as we seek to improve the Eckerd stores we are acquiring. The portfolio is fundamentally sound, with valuable real estate and associates. We believe that the stores will benefit considerably from our leading-edge technology and expertise in important areas such as merchandising, logistics, customer service and marketing. We will pursue a wide range of initiatives designed to improve the stores' focus on inventory management, market-oriented pricing and building customer loyalty through our ExtraCare program. We are confident that our success in these areas will lead to enhanced sales growth, margin expansion and increased profitability at the acquired operations," Mr. Ryan concluded.

CVS expects that its enhanced market position in the South will enable it to achieve annual cost synergies through economies of scale in advertising, distribution and purchasing, as well as other SG&A efficiencies. The Company's enhanced presence in the South will also strengthen service to current customers who travel south from other markets by enabling them to utilize CVS for their pharmacy needs throughout the year.

Dave Rickard, Chief Financial Officer, said: "The purchase price is very attractive on a purely cash economics basis and the transaction will provide significant long-term strategic benefits. The purchase price represents a multiple of 0.30x net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 acquired. In addition, we expect the transaction to add approximately $150 million to our cash flow in 2005, even after a significant infusion of capital for stores and systems."

Mr. Rickard continued: "We expect this acquisition to be 12 to 15 cents dilutive to 2004 earnings per share, after integration and non-recurring expenses associated with the transaction. We expect the transaction to be 15 to 20 cents accretive to 2005 earnings per share and to be 25 to 30 cents accretive to 2006 earnings per share."

CVS expects to finance the transaction with a combination of short- and long-term debt Long-Term Debt

Loans and financial obligations lasting over one year.

Notes:
For example debts obligations such as bonds and notes which have maturities greater than one year would be considered long-term debt.
. Closing of the transaction, which is expected to occur in June of 2004, is subject to review under the Hart-Scott-Rodino Act Hart-Scott-Rodino Act

Often used in risk arbitrage. Antitrust act administered by U.S. Department of Justice and the FTC that requires an investor to file a form with the government before he acquires an economic interest in the lesser amount of $15 million or 15% of the
, as well as customary closing conditions.

CVS will be holding a conference call today for the investment community at 9:00 a.m. (EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
) to discuss this transaction. The call will be simulcast on the Company's Web site for all interested parties. To access the webcast, visit the Company's Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Web site at http://investor.CVS.com to hear the call live, or to listen to an archive of the call which will be available for a one-week period following the call.

With more than 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. General information about CVS is available through the Investor Relations portion of the Company's website, at http://investor.CVS.com.

This press release contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For these statements, the Company claims the protection of the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 for forward-looking statements contained in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The Company strongly recommends that you become familiar with the specific risks and uncertainties outlined under the caption "Cautionary Statement Concerning Forward-Looking Statements" in its Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the fiscal year ended January 3, 2004.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 5, 2004
Words:941
Previous Article:Multimedia Available: Bruker Daltonics Appoints Mr. Seiichiro Tsurumaki as Assistant Vice President for Japan.
Next Article:The NPD Group Reports on Low-Carb's Impact on America's Diet; NPD's New Study Finds Actual Carb Consumption is Higher Than Expected.
Topics:



Related Articles
Vying for Viagra.
CVS Corporation March Sales Increase 9.5%.
CVS Corporation April Sales Increase 7%.
FTC Grants Early Termination of Waiting Period For CVS/Eckerd Transaction.
CVS Corporation Completes Acquisition of 1,260 Eckerd Stores and PBM/Mail Order Pharmacy Business.
Look at the big economic picture: Ron Johnson says in a changing economy, company performance drives portfolio growth.
Healthcare: schemes tackle rise in prescription costs.
Don't trust the middleman: pharmacy benefits managers can exploit their position at the center of a complex drug-delivery system to rip off consumers.
Special delivery: most studies show mail-order pharmacies save money for insurers and consumers, but retail stores are demanding to be an option,...
Drug chain swallows up 12,000 s/f sublease space.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles